Medilab Diagnostic & Polyclinic Pvt Ltd
Provides pathology lab services since 1992 in West Bengal.
1992 | Midnapore, West Bengal (India) | Active
Medilab Diagnostic & Polyclinic Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.52 M
- Company Age 32 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 5.05%
- Profit Growth 60.47%
- Ebitda -0.91%
- Net Worth 104.24%
- Total Assets -4.33%
About Medilab Diagnostic & Polyclinic
Medilab Diagnostic & Polyclinic Pvt Ltd (MDPPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 September 1992 and has a history of 32 years and five months. Its registered office is in Midnapore, West Bengal, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.52 M, as per Ministry of Corporate Affairs (MCA) records.
Manju Chatterjee, Sukla Sarkar, and Ambuprabha Sarkar serve as directors at the Company.
Company Details
- Location
Midnapore, West Bengal, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85195WB1992PTC056579
- Company No.
056579
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Sep 1992
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Healthcare
Who are the key members and board of directors at Medilab Diagnostic & Polyclinic?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manju Chatterjee  | Director | 09-Sep-1993 | Current |
| Sukla Sarkar | Director | 09-Sep-1993 | Current |
| Ambuprabha Sarkar | Director | 09-Sep-1993 | Current |
Financial Performance of Medilab Diagnostic & Polyclinic.
Medilab Diagnostic & Polyclinic Pvt Ltd, for the financial year ended 2022, experienced modest growth in revenue, with a 5.05% increase. The company also saw a substantial improvement in profitability, with a 60.47% increase in profit. The company's net worth Soared by an impressive increase of 104.24%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medilab Diagnostic & Polyclinic?
In 2021, Medilab Diagnostic & Polyclinic had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Medilab Diagnostic & Polyclinic?
Unlock and access historical data on people associated with Medilab Diagnostic & Polyclinic, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medilab Diagnostic & Polyclinic, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medilab Diagnostic & Polyclinic's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.